Tenaya Therapeutics Inc (TNYA)
4.25
-0.41
(-8.80%)
USD |
NASDAQ |
May 20, 16:00
4.255
0.00 (0.00%)
After-Hours: 20:00
Tenaya Therapeutics 1 Year Total Returns (Daily): -42.26% for May 20, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 20, 2024 | -42.26% |
May 17, 2024 | -34.83% |
May 16, 2024 | -36.85% |
May 15, 2024 | -39.29% |
May 14, 2024 | -35.01% |
May 13, 2024 | -36.78% |
May 10, 2024 | -38.24% |
May 09, 2024 | -31.39% |
May 08, 2024 | -29.53% |
May 07, 2024 | -32.21% |
May 06, 2024 | -33.24% |
May 03, 2024 | -20.81% |
May 02, 2024 | -12.17% |
May 01, 2024 | -21.08% |
April 30, 2024 | -14.58% |
April 29, 2024 | -14.58% |
April 26, 2024 | -8.59% |
April 25, 2024 | -22.92% |
April 24, 2024 | -24.61% |
April 23, 2024 | -19.82% |
April 22, 2024 | -20.18% |
April 19, 2024 | 20.50% |
April 18, 2024 | 40.20% |
April 17, 2024 | 44.30% |
April 16, 2024 | 55.40% |
Date | Value |
---|---|
April 15, 2024 | 55.75% |
April 12, 2024 | 55.94% |
April 11, 2024 | 55.30% |
April 10, 2024 | 58.87% |
April 09, 2024 | 70.30% |
April 08, 2024 | 74.06% |
April 05, 2024 | 77.65% |
April 04, 2024 | 69.63% |
April 03, 2024 | 76.75% |
April 02, 2024 | 61.05% |
April 01, 2024 | 75.09% |
March 28, 2024 | 95.15% |
March 27, 2024 | 95.45% |
March 26, 2024 | 90.91% |
March 25, 2024 | 92.09% |
March 22, 2024 | 80.50% |
March 21, 2024 | 70.71% |
March 20, 2024 | 87.74% |
March 19, 2024 | 81.20% |
March 18, 2024 | 92.80% |
March 15, 2024 | 89.52% |
March 14, 2024 | 82.06% |
March 13, 2024 | 89.82% |
March 12, 2024 | 112.6% |
March 11, 2024 | 111.5% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-93.72%
Minimum
Nov 08 2022
131.5%
Maximum
Feb 16 2024
-25.07%
Average
-25.02%
Median
1 Year Total Returns (Daily) Benchmarks
Biomarin Pharmaceutical Inc | -16.16% |
Corvus Pharmaceuticals Inc | -28.53% |
Solid Biosciences Inc | 52.00% |
Dyne Therapeutics Inc | 158.2% |
Sana Biotechnology Inc | 21.21% |